Verano Holdings Q2 $222M Revenue In Line QoQ, Net Loss Widens To $22M Ahead of Cannabist Co. Acquisition

Zinger Key Points
  • Verano disclosed Q2 revenues of $222 million, up 0.5% sequentially and meeting its guidance.
  • ‘We are prepared to leverage near-term catalysts including this week’s launch of Ohio adult use sales,’ the CEO said.

Chicago-based multi-state cannabis operator Verano Holdings Corp. VRNOF reported its financial results Wednesday for the second quarter ended June 30, 2024. The company disclosed revenues of $222 million, up 0.5% sequentially and meeting its guidance. On a year-over-year basis, revenue dropped 5%.

Financial results follow the company's announcement to acquire significant assets from The Cannabist Company Holdings Inc. CBSTF. The acquisition, strategic to expanding its national footprint, includes one of Cannabist's Virginia licenses, along with associated operations including all operations in Arizona.

"Our second quarter performance was strong, highlighted by proactive measures we executed to further bolster the business, including authorization of a share repurchase program, capex investments, and subsequent to quarter end, strategic M&A that upon closure, will grant us vertical access to the Virginia market ahead of adult use," stated George Archos, Verano founder and chief executive officer.

"Looking ahead, we are prepared to leverage near-term catalysts including this week's launch of Ohio adult use sales, positive polling trends in Florida showing strengthening support of Amendment 3, ongoing adult use discussions in Pennsylvania, and continued rescheduling momentum at the federal level," Archos continued. "Adding Virginia to our portfolio and deepening our robust Arizona business also provides additional growth opportunities regardless of federal rescheduling timing and progress. We remain excited and confident in Verano's ability to continue driving long-term, sustainable growth throughout 2024 and beyond."


Read Also: Verano To Repurchase Up To $50M Of Its Shares Trading On Cboe Canada

Second Quarter 2024 Financial Highlights

  • Gross profit amounted to $114.34 million or 51% of revenue, which compares to $115.19 million and 49% in the same quarter last year.
  • Net loss was $(21.76) million or (10%) of revenue, compared to a net loss $(13.06) million in the corresponding period of 2023.
  • Adjusted EBITDA was a gain of $70.59 million or 32% of revenue, which compares to adjusted EBITDA of $71.51 million in the second quarter of 2023.
  • SG&A expenses reached $87 million or 39% of revenue, up from $85 million or 36% of revenue for the second quarter of 2023.
  • Net cash provided by operating activities year to date was $39 million, down from $41 million for the prior year period.
  • Capital expenditures year to date were $28 million, up from $17 million for the prior year period.

2024 Guidance

The company is not issuing guidance given the timing and uncertainties surrounding the closing of the pending acquisitions of The Cannabist Company’s operations.

As of June 30, 2024, the Verano's assets were $358 million, including cash and cash equivalents of $130 million. The company had a working capital deficit of $(3) million and total debt, net of issuance costs, of $396 million.

Price Action

Verano shares closed Tuesday market session 0.35% higher at $3.41 per share.

Read Next:

CCC banner https://www.benzinga.com/events/cannabis-conference/
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsCannabis EarningsGeorge Archospremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.